Spasticity in MND Improved With Cannabinoid Oral Spray

Nabiximols, a cannabinoid-based oral spray approved outside the US for MS symptoms, shows improvement of spasticity in amyotrophic and primary lateral sclerosis when used as add-on therapy.
Medscape Medical News

Source link

Related posts

Congresswoman Louise M. Slaughter (1929-2018)


Zebra sign specific to ALS or not


Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy